May 17, 2010
Lonza to construct vitamin B3 plant in China
Swiss ingredients manufacturer Lonza has decided to locate its new vitamin B3 manufacturing site at Nansha, China and this investment will cost CHF50 million (US$45 million).
The construction of a new nicotinate plant will help the company meet growing market demand, fulfil long-term customer commitments and support and grow Lonza's global leadership in vitamin B3.
The new plant will serve the global and Chinese food, animal feed, pharmaceutical and cosmetic markets.
The Nansha facility will provide an additional 15,000 tonnes of product per year, increasing current capacity by more than 40%. The capacity will be added in phases, with the first phase expected to come on stream in 2011, followed by full operation in 2012.
Nicotinates, including both nicotinic acid and nicotinamide, are vitamin B3 supplements used in the food, animal feed and pharmaceutical industries.
